Beyond the physical, a prostate cancer diagnosis carries significant emotional weight. Understanding this spectrum of ...

Obesity and prostate cancer are two very common diagnoses in older men, and several studies have found a relationship between excess weight and prostate cancer progression. “The diagnosis of cancer is ...

As a physician, researcher, and biotech leader with personal experience of prostate cancer in my family, I’ve long advocated for putting patients first in our quest for medical innovation. Today, I ...

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy. When blocked, these enzymes cause the androgen receptor to collapse, ...

For people battling prostate cancer, the fight can feel like a contest between the disease and the doctors. Their body is the battlefield, but they may nonetheless feel marginalized—more bystander ...

Hormone therapy, regardless of duration, after salvage radiation may delay metastasis and prostate cancer death. Both short- and long-course hormone therapy (HT) after postoperative radiation therapy ...

GG1 prostate cancer can have heterogeneous outcomes, with some patients having intermediate- or high-risk disease, challenging the notion of GG1 as uniformly low-risk. Removing the cancer label for ...

Two-Week Radiotherapy Proven as Safe and Effective as Eight-Week Course for Prostate Cancer, After 10-Year Follow-Up in Phase III Trial Vienna, Austria — Prostate cancer is the most commonly diagnosed ...